Some sufferers survived from 21 to 23 weeks. Zagon said preclinical studies of OGF suggest that it might be useful in the treatment of other cancers that rely on OGF for development such as colon, neck and head, kidney and developing anxious system. The investigators are enrolling sufferers in a larger currently, phase II research of OGF for the treating pancreatic cancers sponsored by the National Institutes of Health. For more information or to end up being evaluated for inclusion in the trial, contact Sandra Bingaman, R.N., study coordinator, at 531-8108.. A booster dosage of a substance currently found in the body appears to be safe and nontoxic for the treating pancreatic cancer A booster dose of a substance already found in the body is apparently safe and nontoxic for the treating pancreatic cancer, and displays signals of arresting pancreatic cancer cell growth in sufferers, Penn State College of Medicine researchers record.Public’s perception. Related StoriesStudy shows fifty % of adolescents misuse their prescription drugsNew research reveals regional variations used of heroin and prescription painkillersCommon drug used for dealing with fungal infections in lung transplant recipients boosts risk for skin cancer, deathKey Findings from Cliffside Malibu’s Review: The upsurge in the proportion of individuals searching for treatment for prescription drug and painkiller addiction unrelated to damage has elevated 143 percent since 2005 .1 percent from 2007 to 2008 Xanax is the most abused material among patients admitted for treatment of prescription medication addiction , followed by Oxycontin and Klonopin.Beginning in 2007, increasing numbers of individuals cited the country’s finances as a major reason behind elevated anxiety levels.